Pain Relief Patches Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for pain relief patches. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights: Pain Relief Patches Market

Market Size (2024E): USD 1.2 Billion
Projected Market Value (2033F): USD 1.9 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 5.2%

Pain Relief Patches Market - Report Scope:

Pain relief patches play a crucial role in the treatment of various types of pain, offering localized relief through transdermal delivery of active pharmaceutical ingredients (APIs). These patches are used widely in clinical settings, homecare environments, and sports medicine, providing alternatives to oral medications and invasive treatments. The market caters to a diverse range of pain conditions, including musculoskeletal pain, arthritis, and post-operative pain management.

Market Growth Drivers:

The global pain relief patches market is driven by several key factors, including increasing prevalence of chronic pain conditions such as arthritis and lower back pain. The shift towards non-invasive pain management solutions and the preference for localized drug delivery methods contribute significantly to market expansion. Technological advancements in patch design, such as improved adhesion and prolonged drug release capabilities, enhance patient comfort and treatment efficacy, further stimulating market growth.

Market Restraints:

Despite promising growth prospects, the pain relief patches market faces challenges related to regulatory approvals, particularly concerning the classification of patches as medical devices or pharmaceutical products. Variations in reimbursement policies across different regions and concerns regarding skin irritation and allergic reactions associated with certain patch formulations also hinder market penetration.

Market Opportunities:

The pain relief patches market presents significant growth opportunities driven by advancements in patch technology and increasing consumer awareness about non-opioid pain management options. Strategic collaborations between pharmaceutical companies and patch manufacturers to develop innovative formulations and expand market reach are expected to capitalize on emerging opportunities. Moreover, the growing adoption of telemedicine and e-commerce platforms for the distribution of pain relief patches broadens access to these products across diverse patient demographics.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the pain relief patches market globally?
Which pain conditions and patient demographics are driving adoption of pain relief patches?
How are technological advancements reshaping the competitive landscape of the pain relief patches market?
Who are the key players contributing to the pain relief patches market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global pain relief patches market?

Competitive Intelligence and Business Strategy:

Leading players in the global pain relief patches market, including [Company A], [Company B], and [Company C], focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced patch formulations, enhance drug delivery capabilities, and improve patient compliance. Collaborations with healthcare providers and retail distributors facilitate market expansion, while investments in clinical research and regulatory compliance ensure product safety and efficacy.

Key Companies Profiled:

Viatris, Inc. (Mylan)
Johnson & Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Hisamitsu Pharmaceutical Co., Inc.
GlaxoSmithKline Plc.
Novartis AG
Nichiban Co., Ltd.
Teikoku Seiyaku Co, Ltd.
Mentholatum Company
Purdue Pharma L.P.
West-Ward Pharmaceuticals Corporation
Pfizer, Inc
Allergan PLC (Actavis)
Endo International PLC
Mylan N.V.
Corium, Inc.
Agile Therapeutics Inc.

Pain Relief Patches Industry Research Segmentation

By Product Type:

Non-steroidal Anti-inflammatory Drug Patches
Opioid Patches
Local Anesthetic Patches

By Indication:

Menstrual Cramps
Orthopedic Pain
Neuropathic Pain
Post-operative Pain
Cardiovascular Pain
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Product Code: PMRREP33349

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends

4. Key Success Factors

4.1. Key Promotional Strategies, By Key Player
4.2. Product Adoption/Usage Analysis
4.3. Technology Assessment
4.4. Regulatory Scenario
4.5. Value Chain Analysis
4.6. Porter's Analysis
4.7. PESTEL analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Market Outlook
- 5.1.3. Per Capita Healthcare Spending Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Top Companies Historical Growth
- 5.2.2. Product Adoption Rate and Demand
- 5.2.3. New Product Launches
- 5.2.4. Increase in Demand for Non-invasive Pain Management Treatment
- 5.2.5. Changing Regulatory Dynamics
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Indication
- 6.1.3. By Distribution Channel
- 6.1.4. By Region
6.2. 2024 Market Scenario

7. Global Market Pricing Analysis

7.1. Regional Pricing Analysis, By Product Type
7.2. Global Average Pricing Analysis Benchmark
7.3. Pricing Assumptions

8. Global Market Value US$ Mn Analysis 2019-2023 and Forecast, 2024-2033

8.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
8.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
- 8.2.1. Y-o-Y Growth Analysis
- 8.2.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
- 9.3.1. Non-Steroidal Anti- Inflammatory Drug Patches
- 9.3.2. Ketroprofen Patches
- 9.3.3. Diclofenac Patches
- 9.3.4. Flurbiprofen Patches
- 9.3.5. Piroxicam Patches
- 9.3.6. Opioid Patches
- 9.3.7. Fentanyl Patches
- 9.3.8. Buprenorphine
- 9.3.9. Local Anaesthetic Patches
- 9.3.10. Nitro-glycerin Patches
- 9.3.11. Capsaicin Patches
- 9.3.12. Lidocaine Patches
9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
- 10.3.1. Menstrual Cramps
- 10.3.2. Orthopedic Pain
- 10.3.3. Neuropathic Pain
- 10.3.4. Post-Operative Pain
- 10.3.5. Cardiovascular Pain
- 10.3.6. Others
10.4. Market Attractiveness Analysis By Indication

11. Global Market analysis 2019-2023 and forecast 2024-2033, By Distribution Channel

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2024-2033
- 11.3.1. Hospital Pharmacies
- 11.3.2. Retail Pharmacies
- 11.3.3. Online Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. East Asia
- 12.3.5. South Asia
- 12.3.6. Oceania
- 12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. U.S.
  - 13.3.1.2. Canada
- 13.3.2. By Product
- 13.3.3. By Indication
- 13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By Indication
- 13.4.4. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. U.S. Market
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Product
    - 13.8.1.2.2. By Indication
    - 13.8.1.2.3. By Distribution Channel
- 13.8.2. Canada Market
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Product
    - 13.8.2.2.2. By Indication
    - 13.8.2.2.3. By Distribution Channel

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. Brazil
  - 14.3.1.2. Mexico
  - 14.3.1.3. Rest of Latin America
- 14.3.2. By Product
- 14.3.3. By Indication
- 14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Indication
- 14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. Brazil Market
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Product
    - 14.8.1.2.2. By Indication
    - 14.8.1.2.3. By Distribution Channel
- 14.8.2. Argentina Market
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Product
    - 14.8.2.2.2. By Indication
    - 14.8.2.2.3. By Distribution Channel
- 14.8.3. Mexico Market
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Product
    - 14.8.3.2.2. By Indication
    - 14.8.3.2.3. By Distribution Channel

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. Germany
  - 15.3.1.2. Italy
  - 15.3.1.3. France
  - 15.3.1.4. U.K.
  - 15.3.1.5. Spain
  - 15.3.1.6. BENELUX
  - 15.3.1.7. Russia
  - 15.3.1.8. Rest of Europe
- 15.3.2. By Product
- 15.3.3. By Indication
- 15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Indication
- 15.4.4. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. Germany Market
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Product
    - 15.8.1.2.2. By Indication
    - 15.8.1.2.3. By Distribution Channel
- 15.8.2. France Market
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Product
    - 15.8.2.2.2. By Indication
    - 15.8.2.2.3. By Distribution Channel
- 15.8.3. Italy Market
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Product
    - 15.8.3.2.2. By Indication
    - 15.8.3.2.3. By Distribution Channel
- 15.8.4. Spain Market
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.4.2.1. By Product
    - 15.8.4.2.2. By Indication
    - 15.8.4.2.3. By Distribution Channel
- 15.8.5. U.K. Market
  - 15.8.5.1. Introduction
  - 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.5.2.1. By Product
    - 15.8.5.2.2. By Indication
    - 15.8.5.2.3. By Distribution Channel
- 15.8.6. Benelux Union Market
  - 15.8.6.1. Introduction
  - 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.6.2.1. By Product
    - 15.8.6.2.2. By Indication
    - 15.8.6.2.3. By Distribution Channel
- 15.8.7. Russia Market
  - 15.8.7.1. Introduction
  - 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.7.2.1. By Product
    - 15.8.7.2.2. By Indication
    - 15.8.7.2.3. By Distribution Channel

16. South Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Thailand
  - 16.3.1.3. Indonesia
  - 16.3.1.4. Malaysia
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Product
- 16.3.3. By Indication
- 16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Indication
- 16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. India Market
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Product
    - 16.8.1.2.2. By Indication
    - 16.8.1.2.3. By Distribution Channel
- 16.8.2. Indonesia Market
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Product
    - 16.8.2.2.2. By Indication
    - 16.8.2.2.3. By Distribution Channel
- 16.8.3. Thailand Market
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.3.2.1. By Product
    - 16.8.3.2.2. By Indication
    - 16.8.3.2.3. By Distribution Channel
- 16.8.4. Malaysia Market
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.4.2.1. By Product
    - 16.8.4.2.2. By Indication
    - 16.8.4.2.3. By Distribution Channel

17. East Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
- 17.3.2. By Product
- 17.3.3. By Indication
- 17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Indication
- 17.4.4. By Distribution Channel
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
- 17.8.1. China Market
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Product
    - 17.8.1.2.2. By Indication
    - 17.8.1.2.3. By Distribution Channel
- 17.8.2. Japan Market
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Product
    - 17.8.2.2.2. By Indication
    - 17.8.2.2.3. By Distribution Channel
- 17.8.3. South Korea Market
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Product
    - 17.8.3.2.2. By Indication
    - 17.8.3.2.3. By Distribution Channel

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. Australia
  - 18.3.1.2. New Zealand
- 18.3.2. By Product
- 18.3.3. By Indication
- 18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Indication
- 18.4.4. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
- 18.8.1. Australia Market
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.1.2.1. By Product
    - 18.8.1.2.2. By Indication
    - 18.8.1.2.3. By Distribution Channel
- 18.8.2. New Zealand Market
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.2.2.1. By Product
    - 18.8.2.2.2. By Indication
    - 18.8.2.2.3. By Distribution Channel

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

19.1. Introduction
19.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Bn)Analysis and Forecast By Market Taxonomy, 2024-2033
- 19.3.1. By Country
  - 19.3.1.1. GCC Countries
  - 19.3.1.2. Turkiye
  - 19.3.1.3. North Africa
  - 19.3.1.4. South Africa
  - 19.3.1.5. Rest of Middle East and Africa
- 19.3.2. By Product
- 19.3.3. By Indication
- 19.3.4. By Distribution Channel
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Indication
- 19.4.4. By Distribution Channel
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
- 19.8.1. GCC Countries Market
  - 19.8.1.1. Introduction
  - 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.1.2.1. By Product
    - 19.8.1.2.2. By Indication
    - 19.8.1.2.3. By Distribution Channel
- 19.8.2. Turkiye Market
  - 19.8.2.1. Introduction
  - 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.2.2.1. By Product
    - 19.8.2.2.2. By Indication
    - 19.8.2.2.3. By Distribution Channel
- 19.8.3. South Africa Market
  - 19.8.3.1. Introduction
  - 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.3.2.1. By Product
    - 19.8.3.2.2. By Indication
    - 19.8.3.2.3. By Distribution Channel
- 19.8.4. North Africa Market
  - 19.8.4.1. Introduction
  - 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.4.2.1. By Product
    - 19.8.4.2.2. By Indication
    - 19.8.4.2.3. By Distribution Channel

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Technology Footprint

21. Competition Analysis

21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
- 21.3.1. Viatris, Inc. (Mylan)
  - 21.3.1.1. Overview
  - 21.3.1.2. Product Portfolio
  - 21.3.1.3. Key Financials
  - 21.3.1.4. SWOT Analysis
  - 21.3.1.5. Sales Footprint
  - 21.3.1.6. Key Developments
  - 21.3.1.7. Strategy Overview
- 21.3.2. Obalon Therapeutics, Inc.
  - 21.3.2.1. Overview
  - 21.3.2.2. Product Portfolio
  - 21.3.2.3. Key Financials
  - 21.3.2.4. SWOT Analysis
  - 21.3.2.5. Sales Footprint
  - 21.3.2.6. Key Developments
  - 21.3.2.7. Strategy Overview
- 21.3.3. Johnson & Johnson Services, Inc.
  - 21.3.3.1. Overview
  - 21.3.3.2. Product Portfolio
  - 21.3.3.3. Key Financials
  - 21.3.3.4. SWOT Analysis
  - 21.3.3.5. Sales Footprint
  - 21.3.3.6. Key Developments
  - 21.3.3.7. Strategy Overview
- 21.3.4. Teva Pharmaceutical Industries Ltd.
  - 21.3.4.1. Overview
  - 21.3.4.2. Product Portfolio
  - 21.3.4.3. Key Financials
  - 21.3.4.4. SWOT Analysis
  - 21.3.4.5. Sales Footprint
  - 21.3.4.6. Key Developments
  - 21.3.4.7. Strategy Overview
- 21.3.5. Sanofi S.A.
  - 21.3.5.1. Overview
  - 21.3.5.2. Product Portfolio
  - 21.3.5.3. Key Financials
  - 21.3.5.4. SWOT Analysis
  - 21.3.5.5. Sales Footprint
  - 21.3.5.6. Key Developments
  - 21.3.5.7. Strategy Overview
- 21.3.6. Hisamitsu Pharmaceutical Co., Inc.
  - 21.3.6.1. Overview
  - 21.3.6.2. Product Portfolio
  - 21.3.6.3. Key Financials
  - 21.3.6.4. SWOT Analysis
  - 21.3.6.5. Sales Footprint
  - 21.3.6.6. Key Developments
  - 21.3.6.7. Strategy Overview
- 21.3.7. GlaxoSmithKline Plc.
  - 21.3.7.1. Overview
  - 21.3.7.2. Product Portfolio
  - 21.3.7.3. Key Financials
  - 21.3.7.4. SWOT Analysis
  - 21.3.7.5. Sales Footprint
  - 21.3.7.6. Key Developments
  - 21.3.7.7. Strategy Overview
- 21.3.8. Novartis AG
  - 21.3.8.1. Overview
  - 21.3.8.2. Product Portfolio
  - 21.3.8.3. Key Financials
  - 21.3.8.4. SWOT Analysis
  - 21.3.8.5. Sales Footprint
  - 21.3.8.6. Key Developments
  - 21.3.8.7. Strategy Overview
- 21.3.9. Nichiban Co., Ltd.
  - 21.3.9.1. Overview
  - 21.3.9.2. Product Portfolio
  - 21.3.9.3. Key Financials
  - 21.3.9.4. SWOT Analysis
  - 21.3.9.5. Sales Footprint
  - 21.3.9.6. Key Developments
  - 21.3.9.7. Strategy Overview
- 21.3.10. Teikoku Seiyaku Co, Ltd.
  - 21.3.10.1. Overview
  - 21.3.10.2. Product Portfolio
  - 21.3.10.3. Key Financials
  - 21.3.10.4. SWOT Analysis
  - 21.3.10.5. Sales Footprint
  - 21.3.10.6. Key Developments
  - 21.3.10.7. Strategy Overview
- 21.3.11. Mentholatum Company.
  - 21.3.11.1. Overview
  - 21.3.11.2. Product Portfolio
  - 21.3.11.3. Key Financials
  - 21.3.11.4. SWOT Analysis
  - 21.3.11.5. Sales Footprint
  - 21.3.11.6. Key Developments
  - 21.3.11.7. Strategy Overview
- 21.3.12. Purdue Pharma L.P.
  - 21.3.12.1. Overview
  - 21.3.12.2. Product Portfolio
  - 21.3.12.3. Key Financials
  - 21.3.12.4. SWOT Analysis
  - 21.3.12.5. Sales Footprint
  - 21.3.12.6. Key Developments
  - 21.3.12.7. Strategy Overview
- 21.3.13. West-Ward Pharmaceuticals Corporation
  - 21.3.13.1. Overview
  - 21.3.13.2. Product Portfolio
  - 21.3.13.3. Key Financials
  - 21.3.13.4. SWOT Analysis
  - 21.3.13.5. Sales Footprint
  - 21.3.13.6. Key Developments
  - 21.3.13.7. Strategy Overview
- 21.3.14. Pfizer, Inc
  - 21.3.14.1. Overview
  - 21.3.14.2. Product Portfolio
  - 21.3.14.3. Key Financials
  - 21.3.14.4. SWOT Analysis
  - 21.3.14.5. Sales Footprint
  - 21.3.14.6. Key Developments
  - 21.3.14.7. Strategy Overview
- 21.3.15. Allergan Plc (Actavis)
  - 21.3.15.1. Overview
  - 21.3.15.2. Product Portfolio
  - 21.3.15.3. Key Financials
  - 21.3.15.4. SWOT Analysis
  - 21.3.15.5. Sales Footprint
  - 21.3.15.6. Key Developments
  - 21.3.15.7. Strategy Overview
- 21.3.16. Endo International plc,
  - 21.3.16.1. Overview
  - 21.3.16.2. Product Portfolio
  - 21.3.16.3. Key Financials
  - 21.3.16.4. SWOT Analysis
  - 21.3.16.5. Sales Footprint
  - 21.3.16.6. Key Developments
  - 21.3.16.7. Strategy Overview
- 21.3.17. Mylan N.V.
  - 21.3.17.1. Overview
  - 21.3.17.2. Product Portfolio
  - 21.3.17.3. Key Financials
  - 21.3.17.4. SWOT Analysis
  - 21.3.17.5. Sales Footprint
  - 21.3.17.6. Key Developments
  - 21.3.17.7. Strategy Overview